MYGN

Myriad Genetics, Inc. News Headlines

$36.24
*  
0.54
1.47%
Get MYGN Alerts
*Delayed - data as of Jan. 23, 2015  -  Find a broker to begin trading MYGN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
March 6th Options Now Available For Myriad Genetics (MYGN)
1/22/2015 1:36:01 PM - BNK Invest


Myriad Genetics (MYGN) Shares Cross Below 200 DMA
1/21/2015 4:30:48 PM - BNK Invest


Is Myriad Genetics (MYGN) Worth Adding to Your Portfolio? - Analyst Blog
1/16/2015 1:00:00 PM - Investopedia


Is Myriad Genetics (MYGN) Worth Adding to Your Portfolio? - Analyst Blog
1/16/2015 1:00:00 PM - Zacks.com


Can the Rally in Myriad Genetics (MYGN) Shares Continue? - Tale of the Tape
1/13/2015 8:45:15 AM - Zacks.com


Myriad's Tumor-Based Cancer Test Wins CE Mark, Shares Up - Analyst Blog
1/12/2015 2:00:00 PM - Investopedia


Myriad's Tumor-Based Cancer Test Wins CE Mark, Shares Up - Analyst Blog
1/12/2015 2:00:00 PM - Zacks.com


Myriad Genetics To Present At J.P. Morgan Conference; Webcast At 12:30 PM ET
1/12/2015 11:30:00 AM - RTT News


In Case You Missed it, This New Cancer Study is Terrifying
1/10/2015 9:12:04 AM - Motley Fool


Myriad Genetics Gets CE Marking For Its Tumor BRACAnalysis CDx Test
1/8/2015 12:27:00 AM - RTT News


Stocks Holding On To Strong Gains In Mid-Day Trading - U.S. Commentary
1/7/2015 12:05:00 PM - RTT News


Update: Myriad Genetics Won FDA Approval For BRACAnalysis CDx
12/25/2014 11:53:00 AM - Seeking Alpha


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Investopedia


Myriad Genetics' Ovarian Cancer Test Wins FDA Approval - Analyst Blog
12/24/2014 2:10:00 PM - Zacks.com


Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
12/23/2014 2:30:00 PM - Investopedia


Will myRisk Cancer Test Work Wonders for Myriad Genetics? - Analyst Blog
12/23/2014 2:30:00 PM - Zacks.com


Myriad Genetics Appoints Bernard Tobin As President Of Crescendo Bioscience
12/22/2014 7:17:00 AM - RTT News


JAZZ Hits Right Note, ENTA's Purse Set To Fatten, AEZS Put On Notice
12/21/2014 11:36:00 PM - RTT News


Myriad Genetics Breaks Above 200-Day Moving Average - Bullish for MYGN
12/19/2014 4:31:46 PM - BNK Invest


Seeking Alpha's Biotech Weekly: A Merck Purchase, Spectacular Auspex, And More
12/19/2014 4:00:00 PM - Seeking Alpha


Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog
12/17/2014 4:50:00 PM - Zacks.com


Genomic Health's Oncotype DX Positive in Multiple Studies - Analyst Blog
12/17/2014 4:50:00 AM - Investopedia


Myriad Genetics Unveils Positive Cancer Study Results - Analyst Blog
12/10/2014 1:30:00 PM - Zacks.com


Genomic Health's Oncotype DX: Cancer Testing Made Easier - Analyst Blog
12/4/2014 2:40:00 PM - Zacks.com


Myriad Genetics' Prolaris: A Pocket-Friendly Cancer Test - Analyst Blog
12/3/2014 2:00:00 PM - Zacks.com